The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3369-3380

  Williams, Tere M ^a   Leeth, Rachel A ^a   Rothschild, Daniel E ^a   Coutermarsh Ott, Sheryl L ^a   McDaniel, Dylan K ^a   Simmons, Alysha E ^a   Heid, Bettina ^a   Cecere, Thomas E ^a   Allen, Irving C ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING DOMAIN AND LEUCINE RICH REPEAT PROTEIN 1; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; NLRP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL COMPARTMENTALIZATION; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DIGESTIVE SYSTEM INFLAMMATION; EPITHELIUM CELL; IMMUNE RESPONSE; MALE; MOLECULAR PATHOLOGY; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROSPECTIVE STUDY; TUMOR VOLUME; WILD TYPE; ANIMAL; BIOPSY; CELL TRANSFORMATION; CHEMICALLY INDUCED; COLONIC NEOPLASMS; COMPLICATION; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MORTALITY; PATHOLOGY; ULCERATIVE COLITIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BIOPSY; CELL TRANSFORMATION, NEOPLASTIC; COLITIS; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION; HUMANS; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; MALE; MICE; MICE, KNOCKOUT; RETROSPECTIVE STUDIES;

EID: 84925850795     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402098     Document Type: Article

References (59)

1. Walsh, D., J. McCarthy, C. O'Driscoll, and S. Melgar. 2013. Pattern recognition receptors - molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev. 24: 91-104.
2. Allen, I. C. 2014. Non-inflammasome forming NLRs in inflammation and tumorigenesis. Front. Immunol. 5: 169.
3. Davis, B. K., C. Philipson, R. Hontecillas, K. Eden, J. Bassaganya-Riera, and I. C. Allen. 2014. Emerging significance of NLRs in inflammatory bowel disease. Inflamm. Bowel Dis. 20: 2412-2432.
4. Allen, I. C., E. M. TeKippe, R. M. Woodford, J. M. Uronis, E. K. Holl, A. B. Rogers, H. H. Herfarth, C. Jobin, and J. P. Ting. 2010. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207: 1045-1056.
5. Dupaul-Chicoine, J., G. Yeretssian, K. Doiron, K. S. Bergstrom, C. R. McIntire, P. M. LeBlanc, C. Meunier, C. Turbide, P. Gros, N. Beauchemin, et al. 2010. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32: 367-378.
6. Elinav, E., T. Strowig, A. L. Kau, J. Henao-Mejia, C. A. Thaiss, C. J. Booth, D. R. Peaper, J. Bertin, S. C. Eisenbarth, J. I. Gordon, and R. A. Flavell. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145: 745-757.
7. Hu, B., E. Elinav, S. Huber, C. J. Booth, T. Strowig, C. Jin, S. C. Eisenbarth, and R. A. Flavell. 2010. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl. Acad. Sci. USA 107: 21635-21640.
8. Zaki, M. H., K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T. D. Kanneganti. 2010. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32: 379-391.
9. Schroder, K., and J. Tschopp. 2010. The inflammasomes. Cell 140: 821-832.
10. Ting, J. P., and B. K. Davis. 2005. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 23: 387-414.
11. Ting, J. P., R. C. Lovering, E. S. Alnemri, J. Bertin, J. M. Boss, B. K. Davis, R. A. Flavell, S. E. Girardin, A. Godzik, J. A. Harton, et al. 2008. The NLR gene family: a standard nomenclature. Immunity 28: 285-287.
12. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10: 417-426.
13. Zaki, M. H., P. Vogel, M. Body-Malapel, M. Lamkanfi, and T. D. Kanneganti. 2010. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J. Immunol. 185: 4912-4920.
14. Hu, B., E. Elinav, S. Huber, T. Strowig, L. Hao, A. Hafemann, C. Jin, C. Wunderlich, T. Wunderlich, S. C. Eisenbarth, and R. A. Flavell. 2013. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc. Natl. Acad. Sci. USA 110: 9862-9867.
15. Normand, S., A. Delanoye-Crespin, A. Bressenot, L. Huot, T. Grandjean, L. Peyrin-Biroulet, Y. Lemoine, D. Hot, and M. Chamaillard. 2011. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. USA 108: 9601-9606.
16. Chen, G. Y., M. Liu, F. Wang, J. Bertin, and G. Núñez. 2011. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186: 7187-7194.
17. Jin, Y., S. A. Birlea, P. R. Fain, and R. A. Spritz. 2007. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J. Invest. Dermatol. 127: 2558-2562.
18. Levandowski, C. B., C. M. Mailloux, T. M. Ferrara, K. Gowan, S. Ben, Y. Jin, K. K. McFann, P. J. Holland, P. R. Fain, C. A. Dinarello, and R. A. Spritz. 2013. NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proc. Natl. Acad. Sci. USA 110: 2952-2956.
19. Magitta, N. F., A. S. Bøe Wolff, S. Johansson, B. Skinningsrud, B. A. Lie, K. M. Myhr, D. E. Undlien, G. Joner, P. R. Njølstad, T. K. Kvien, et al. 2009. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun. 10: 120-124.
20. Pontillo, A., A. Vendramin, E. Catamo, A. Fabris, and S. Crovella. 2011. The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am. J. Gastroenterol. 106: 539-544.
21. Cummings, J. R., R. M. Cooney, G. Clarke, J. Beckly, A. Geremia, S. Pathan, L. Hancock, C. Guo, L. R. Cardon, and D. P. Jewell. 2010. The genetics of NOD-like receptors in Crohn's disease. Tissue Antigens 76: 48-56.
22. De Iudicibus, S., G. Stocco, S. Martelossi, M. Londero, E. Ebner, A. Pontillo, P. Lionetti, A. Barabino, F. Bartoli, A. Ventura, and G. Decorti. 2011. Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases. J. Clin. Gastroenterol. 45: e1-e7.
23. Faustin, B., L. Lartigue, J. M. Bruey, F. Luciano, E. Sergienko, B. Bailly-Maitre, N. Volkmann, D. Hanein, I. Rouiller, and J. C. Reed. 2007. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25: 713-724.
24. Boyden, E. D., and W. F. Dietrich. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38: 240-244.
25. Kovarova, M., P. R. Hesker, L. Jania, M. Nguyen, J. N. Snouwaert, Z. Xiang, S. E. Lommatzsch, M. T. Huang, J. P. Ting, and B. H. Koller. 2012. NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in mice. J. Immunol. 189: 2006-2016.
26. Witola, W. H., E. Mui, A. Hargrave, S. Liu, M. Hypolite, A. Montpetit, P. Cavailles, C. Bisanz, M. F. Cesbron-Delauw, G. J. Fournié, and R. McLeod. 2011. NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells. Infect. Immun. 79: 756-766.
27. Cirelli, K. M., G. Gorfu, M. A. Hassan, M. Printz, D. Crown, S. H. Leppla, M. E. Grigg, J. P. Saeij, and M. Moayeri. 2014. Inflammasome sensor NLRP1 controls rat macrophage susceptibility to Toxoplasma gondii. PLoS Pathog. 10: e1003927.
28. Ewald, S. E., J. Chavarria-Smith, and J. C. Boothroyd. 2014. NLRP1 is an inflammasome sensor for Toxoplasma gondii. Infect. Immun. 82: 460-468.
29. Masters, S. L., M. Gerlic, D. Metcalf, S. Preston, M. Pellegrini, J. A. O'Donnell, K. McArthur, T. M. Baldwin, S. Chevrier, C. J. Nowell, et al. 2012. NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 37: 1009-1023.
30. Chavarría-Smith, J., and R. E. Vance. 2013. Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor. PLoS Pathog. 9: e1003452.
31. Gorfu, G., K. M. Cirelli, M. B. Melo, K. Mayer-Barber, D. Crown, B. H. Koller, S. Masters, A. Sher, S. H. Leppla, M. Moayeri, et al. 2014. Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to Toxoplasma gondii. MBio 5: 5.
32. Mariathasan, S., K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, and V. M. Dixit. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218.
33. Wirtz, S., C. Neufert, B. Weigmann, and M. F. Neurath. 2007. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2: 541-546.
34. Neufert, C., C. Becker, and M. F. Neurath. 2007. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc. 2: 1998-2004.
35. Allen, I. C., J. E. Wilson, M. Schneider, J. D. Lich, R. A. Roberts, J. C. Arthur, R. M. Woodford, B. K. Davis, J. M. Uronis, H. H. Herfarth, et al. 2012. NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity 36: 742-754.
36. Meira, L. B., J. M. Bugni, S. L. Green, C. W. Lee, B. Pang, D. Borenshtein, B. H. Rickman, A. B. Rogers, C. A. Moroski-Erkul, J. L. McFaline, et al. 2008. DNA damage induced by chronic inflammation contributes to colon carcino-genesis in mice. J. Clin. Invest. 118: 2516-2525.
37. Allen, I. C., C. M. Jania, J. E. Wilson, E. M. Tekeppe, X. Hua, W. J. Brickey, M. Kwan, B. H. Koller, S. L. Tilley, and J. P. Ting. 2012. Analysis of NLRP3 in the development of allergic airway disease in mice. J. Immunol. 188: 2884-2893.
38. Cressman, V. L., E. M. Hicks, W. K. Funkhouser, D. C. Backlund, and B. H. Koller. 1998. The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice. Am. J. Respir. Cell Mol. Biol. 19: 853-866.
39. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
40. Holl, E. K. 2013. Generation of bone marrow and fetal liver chimeric mice. Methods Mol. Biol. 1032: 315-321.
41. Kupershmidt, I., Q. J. Su, A. Grewal, S. Sundaresh, I. Halperin, J. Flynn, M. Shekar, H. Wang, J. Park, W. Cui, et al. 2010. Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5: 5.
42. Wlodarska, M., C. A. Thaiss, R. Nowarski, J. Henao-Mejia, J. P. Zhang, E. M. Brown, G. Frankel, M. Levy, M. N. Katz, W. M. Philbrick, et al. 2014. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156: 1045-1059.
43. Su, L., L. Shen, D. R. Clayburgh, S. C. Nalle, E. A. Sullivan, J. B. Meddings, C. Abraham, and J. R. Turner. 2009. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 136: 551-563.
44. Carvalho, F. A., I. Nalbantoglu, J. D. Aitken, R. Uchiyama, Y. Su, G. H. Doho, M. Vijay-Kumar, and A. T. Gewirtz. 2012. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol. 5: 288-298.
45. Satsangi, J., R. A. Wolstencroft, J. Cason, C. C. Ainley, D. C. Dumonde, and R. P. Thompson. 1987. Interleukin 1 in Crohn's disease. Clin. Exp. Immunol. 67: 594-605.
46. Reinecker, H. C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R. P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumour necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94: 174-181.
47. McAlindon, M. E., C. J. Hawkey, and Y. R. Mahida. 1998. Expression of interleukin 1β and interleukin 1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease. Gut 42: 214-219.
48. Ben-Sasson, S. Z., J. Hu-Li, J. Quiel, S. Cauchetaux, M. Ratner, I. Shapira, C. A. Dinarello, and W. E. Paul. 2009. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc. Natl. Acad. Sci. USA 106: 7119-7124.
49. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
50. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
51. Chung, Y., S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva, H. S. Kang, L. Ma, S. S. Watowich, A. M. Jetten, Q. Tian, and C. Dong. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30: 576-587.
52. + Th17 cells. J. Exp. Med. 209: 1595-1609.
53. + T cell differentiation and phenotype plasticity. PLOS Comput. Biol. 9: e1003027.
54. Leach, S. T., I. Messina, D. A. Lemberg, D. Novick, M. Rubenstein, and A. S. Day. 2008. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm. Bowel Dis. 14: 68-74.
55. Ben Aleya, W., I. Sfar, I. Habibi, L. Mouelhi, H. Aouadi, M. Makhlouf, S. Ayed-Jendoubi, T. Najjar, T. Ben Abdallah, K. Ayed, and Y. Gorgi. 2011. Interleukin-18 gene polymorphisms in tunisian patients with inflammatory bowel disease. Digestion 83: 269-274.
56. Sivakumar, P. V., G. M. Westrich, S. Kanaly, K. Garka, T. L. Born, J. M. Derry, and J. L. Viney. 2002. Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage. Gut 50: 812-820.
57. Araki, A., T. Kanai, T. Ishikura, S. Makita, K. Uraushihara, R. Iiyama, T. Totsuka, K. Takeda, S. Akira, and M. Watanabe. 2005. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J. Gastroenterol. 40: 16-23.
58. Salcedo, R., A. Worschech, M. Cardone, Y. Jones, Z. Gyulai, R. M. Dai, E. Wang, W. Ma, D. Haines, C. O'hUigin, et al. 2010. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207: 1625-1636.
59. Bersudsky, M., L. Luski, D. Fishman, R. M. White, N. Ziv-Sokolovskaya, S. Dotan, P. Rider, I. Kaplanov, T. Aychek, C. A. Dinarello, et al. 2014. Nonredundant properties of IL-1α and IL-1β during acute colon inflammation in mice. Gut 63: 598-609.